Antidote raises $22 million to expand its healthcare services in the United States

Antidote Health, an Israeli telehealth business, revealed this week that it has secured $22 million in Series A investment to advance its R&D efforts and expand its inexpensive healthcare services across the United States.

"With this Series A fundraising round, Antidote Health will be able to serve Americans in more ways than ever before by introducing chronic and primary care services backed by our revolutionary technology ....